Advantage of post-operative oral administration of UFT (Tegafur and Uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC)

By Tanaka F.   Miyahara R.   Ohtake Y.   Yanagihara K.   Fukuse T.   Hitomi S.   Wada H.  

European Journal of Cardio-Thoracic Surgery, Vol. 14, Iss. 3, 1998-09 ,pp. : 256-262

Elsevier

Access to resources Recommend Favorite

Advantage of postoperative oral administration of UFT (Tegafur and Uracil) for completely resected p-Stage I-IIIa non-small cell lung cancer (NSCLC)

By Maggi G.   Ruffini E.  

European Journal of Cardio-Thoracic Surgery, Vol. 14, Iss. 3, 1998-09 ,pp. : 263-264

Elsevier

Access to resources Recommend Favorite

Recurrence-free survival and prognostic factors in resected pN2 non-small cell lung cancer

By Choi Y.S.   Shim Y.M.   Kim J.   Kim K.  

European Journal of Cardio-Thoracic Surgery, Vol. 22, Iss. 5, 2002-11 ,pp. : 695-700

Elsevier

Access to resources Recommend Favorite

Long-term survivors with pN2 non-small cell lung cancer after a complete resection with a systematic mediastinal node dissection

By Yano T.   Fukuyama Y.   Yokoyama H.   Kuninaka S.   Terazaki Y.   Uehara T.   Asoh H.   Ichinose Y.  

European Journal of Cardio-Thoracic Surgery, Vol. 14, Iss. 2, 1998-08 ,pp. : 152-155

Elsevier

Access to resources Recommend Favorite

Present status of induction treatment in stage IIIA-N2 non-small cell lung cancer: a review

By Vansteenkiste J.   De Leyn P.   Deneffe G.   Menten J.   Lerut T.   Demedts M.   The Leuven Lung Cancer Group  

European Journal of Cardio-Thoracic Surgery, Vol. 13, Iss. 1, 1998-01 ,pp. : 1-12

Elsevier

Access to resources Recommend Favorite